Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts

Maternal primary and non-primary cytomegalovirus (CMV) infection during pregnancy can result in in utero transmission to the developing fetus. Congenital CMV (cCMV) can result in significant morbidity, mortality or long-term sequelae, including sensorineural hearing loss, the most common sequela. As...

Full description

Bibliographic Details
Main Authors: Tiziana Lazzarotto, Daniel Blázquez-Gamero, Marie-Luce Delforge, Ina Foulon, Suzanne Luck, Susanne Modrow, Marianne Leruez-Ville
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00013/full
id doaj-818f30164ac24f12a869ab65637b8638
record_format Article
spelling doaj-818f30164ac24f12a869ab65637b86382020-11-25T01:13:07ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-01-01810.3389/fped.2020.00013499925Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European ExpertsTiziana Lazzarotto0Daniel Blázquez-Gamero1Marie-Luce Delforge2Ina Foulon3Suzanne Luck4Suzanne Luck5Susanne Modrow6Marianne Leruez-Ville7Virology Lab, Polyclinic St. Orsola Malpighi, University of Bologna, Bologna, ItalyPediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación Hospital 12 de Octubre (Imas12), Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, SpainCUB-Hôpital Erasme, Université Libre Bruxelles, Brussels, BelgiumDepartment of Otolaryngology - Head and Neck Surgery, Vrije Universiteit Brussel, Brussels, BelgiumKingston Hospital NHS Trust, Kingston upon Thames, United KingdomPaediatric Infectious Diseases Research Group, St George's University of London, London, United KingdomInstitute of Medical Microbiology, University of Regensburg, Regensburg, GermanyHôpital Necker-Enfants Malades and Université Paris Descartes, Paris, FranceMaternal primary and non-primary cytomegalovirus (CMV) infection during pregnancy can result in in utero transmission to the developing fetus. Congenital CMV (cCMV) can result in significant morbidity, mortality or long-term sequelae, including sensorineural hearing loss, the most common sequela. As a leading cause of congenital infections worldwide, cCMV infection meets many of the criteria for screening. However, currently there are no universal programs that offer maternal or neonatal screening to identify infected mothers and infants, no vaccines to prevent infection, and no efficacious and safe therapies available for the treatment of maternal or fetal CMV infection. Data has shown that there are several maternal and neonatal screening strategies, and diagnostic methodologies, that allow the identification of those at risk of developing sequelae and adequately detect cCMV. Nevertheless, many questions remain unanswered in this field. Well-designed clinical trials to address several facets of CMV treatment (in pregnant women, CMV-infected fetuses and both symptomatic and asymptomatic neonates and children) are required. Prevention (vaccines), biology and transmission factors associated with non-primary CMV, and the cost-effectiveness of universal screening, all demand further exploration to fully realize the ultimate goal of preventing cCMV. In the meantime, prevention of primary infection during pregnancy should be championed to all by means of hygiene education.https://www.frontiersin.org/article/10.3389/fped.2020.00013/fullcytomegalovirusneonatal screeningprenatal diagnosisclinical laboratory techniquescongenital CMVpregnancy
collection DOAJ
language English
format Article
sources DOAJ
author Tiziana Lazzarotto
Daniel Blázquez-Gamero
Marie-Luce Delforge
Ina Foulon
Suzanne Luck
Suzanne Luck
Susanne Modrow
Marianne Leruez-Ville
spellingShingle Tiziana Lazzarotto
Daniel Blázquez-Gamero
Marie-Luce Delforge
Ina Foulon
Suzanne Luck
Suzanne Luck
Susanne Modrow
Marianne Leruez-Ville
Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
Frontiers in Pediatrics
cytomegalovirus
neonatal screening
prenatal diagnosis
clinical laboratory techniques
congenital CMV
pregnancy
author_facet Tiziana Lazzarotto
Daniel Blázquez-Gamero
Marie-Luce Delforge
Ina Foulon
Suzanne Luck
Suzanne Luck
Susanne Modrow
Marianne Leruez-Ville
author_sort Tiziana Lazzarotto
title Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
title_short Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
title_full Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
title_fullStr Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
title_full_unstemmed Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
title_sort congenital cytomegalovirus infection: a narrative review of the issues in screening and management from a panel of european experts
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2020-01-01
description Maternal primary and non-primary cytomegalovirus (CMV) infection during pregnancy can result in in utero transmission to the developing fetus. Congenital CMV (cCMV) can result in significant morbidity, mortality or long-term sequelae, including sensorineural hearing loss, the most common sequela. As a leading cause of congenital infections worldwide, cCMV infection meets many of the criteria for screening. However, currently there are no universal programs that offer maternal or neonatal screening to identify infected mothers and infants, no vaccines to prevent infection, and no efficacious and safe therapies available for the treatment of maternal or fetal CMV infection. Data has shown that there are several maternal and neonatal screening strategies, and diagnostic methodologies, that allow the identification of those at risk of developing sequelae and adequately detect cCMV. Nevertheless, many questions remain unanswered in this field. Well-designed clinical trials to address several facets of CMV treatment (in pregnant women, CMV-infected fetuses and both symptomatic and asymptomatic neonates and children) are required. Prevention (vaccines), biology and transmission factors associated with non-primary CMV, and the cost-effectiveness of universal screening, all demand further exploration to fully realize the ultimate goal of preventing cCMV. In the meantime, prevention of primary infection during pregnancy should be championed to all by means of hygiene education.
topic cytomegalovirus
neonatal screening
prenatal diagnosis
clinical laboratory techniques
congenital CMV
pregnancy
url https://www.frontiersin.org/article/10.3389/fped.2020.00013/full
work_keys_str_mv AT tizianalazzarotto congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT danielblazquezgamero congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT marielucedelforge congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT inafoulon congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT suzanneluck congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT suzanneluck congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT susannemodrow congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
AT marianneleruezville congenitalcytomegalovirusinfectionanarrativereviewoftheissuesinscreeningandmanagementfromapanelofeuropeanexperts
_version_ 1725163248727097344